Hafrun Fridriksdottir, Executive VP, Global R&D at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 818 shares at $16.88 ($14K) on 2019-03-04, disclosed to the SEC on 2019-03-05.
Open-market sale of $14k TEVA by Executive VP, Global R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.88 | 409 | $7K | 50.0% |
| 2 | $16.88 | 409 | $7K | 50.0% |
| Total | $16.88 avg | 818 | $14K | 100% |
| Filing → |
| TEVA | SELL | 2022-03-02 | $124K | — | Filing → |
| TEVA | SELL | 2022-02-10 | $111K | — | Filing → |
| TEVA | SELL | 2021-08-12 | $1.0M | — | Filing → |